David Greenwald, Ph.D. is a Managing Director at Deerfield Management, where he invests in healthcare across public and private companies with a therapeutics focus, including ophthalmology, oncology, and CNS. He serves on the boards of Apertura Gene Therapy, Aviko Radiopharmaceuticals, Advanced Medicine Partners, Innervace, and Jaguar Gene Therapy, and has invested in companies like Apertura Gene Therapy, Aviko Radiopharmaceuticals, Innervace, Jaguar Gene Therapy, and Advanced Medicine Partners. Previously, he was Vice President of Business Development at Deerfield Management; Executive Chairman and Acting Chief Executive Officer at Apertura Gene Therapy; Chief Executive Officer at Aviko Radiopharmaceuticals; Executive Chairman at Neutron Therapeutics; a member of the boards of Axovia Therapeutics and the BioTechnical Institute of Maryland, Inc.; and a university lecturer at Johns Hopkins University Advanced Academic Programs. David holds degrees from Tufts University School of Medicine and the University of Maryland and lives in New York, NY.
David Greenwald, Ph.D., Managing Director @ Deerfield Management. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for David Greenwald, Ph.D. from Deerfield Management. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to David
Map your path to David instantly
Connect your network and Draftboard will automatically find and score the strongest paths to David
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.